MICAFUNGIN FOR INJECTION, USP DIN 02568179
Status: Cancelled Pre Market
Holder: BIOCON PHARMA LIMITED
Molecule: MICAFUNGIN SODIUM
Available to quote
Health Canada record
| Active ingredient(s) | MICAFUNGIN SODIUM 50 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J02AX05 MICAFUNGIN |
| Original market date | |
| Current status date | 05-Oct-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MICAFUNGIN SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02532344 | MICAFUNGIN SODIUM FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | MICAFUNGIN SODIUM 50 MG | Marketed |
| 02532360 | MICAFUNGIN SODIUM FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | MICAFUNGIN SODIUM 100 MG | Marketed |
| 02568195 | MICAFUNGIN FOR INJECTION, USP | BIOCON PHARMA LIMITED | Powder For Solution | MICAFUNGIN SODIUM 100 MG | Cancelled Pre Market |
| 02294222 | MYCAMINE | SANDOZ CANADA INCORPORATED | Powder For Solution | MICAFUNGIN SODIUM 50 MG | Cancelled Post Market |
| 02311054 | MYCAMINE | SANDOZ CANADA INCORPORATED | Powder For Solution | MICAFUNGIN SODIUM 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37518 | 2026-05-08 | Abbreviated New Drug Submission (ANDS) |
International API supply for MICAFUNGIN SODIUM
12 active FDA Drug Master Files.
Request a quote for MICAFUNGIN FOR INJECTION, USP